The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Sivolap Yu.P.

Sechenov First Moscow State Medical University (Sechenov University)

Azimova Yu.E.

Scientific Research Institute of General Pathology and Pathophysiology;
University Headache Clinic

Anxiety in neurological practice

Authors:

Sivolap Yu.P., Azimova Yu.E.

More about the authors

Read: 6738 times


To cite this article:

Sivolap YuP, Azimova YuE. Anxiety in neurological practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(5):165‑170. (In Russ.)
https://doi.org/10.17116/jnevro2020120051165

Recommended articles:
Art and creativity in Parkinson’s disease: the mysterious effe­cts of dopa­mine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20
Biochemical features of migraine pathogenesis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):21-26
Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Contemporary aspe­cts of brain protection in aortic arch surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):164-173

References:

  1. Wetherell JL, Lang AJ, Stein MB. Anxiety Disorders. In: Jeste DV, Friedman JH (Eds.). Psychiatry for Neurologists. Current Clinical Neurology. Humana Press. 2006;43-58.  https://doi.org/10.1007/978-1-59259-960-8_5
  2. Rafsten L, Danielsson A, Sunnerhagen KS. Anxiety after stroke: a systematic review and meta-analysis. J Rehabil Med. 2018;50(9):769-778.  https://doi.org/10.2340/16501977-2384
  3. Hadidi NN, Huna Wagner RL, Lindquist R. Nonpharmacological treatments for post-stroke depression: an integrative review of the literature. Res Gerontol Nurs. 2017;10(4):182-195.  https://doi.org/10.3928/19404921-20170524-02
  4. Hadidi N, Treat-Jacobson DJ, Lindquist R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung. 2009;38(2):151-62.  https://doi.org/10.1016/j.hrtlng.2008.05.002
  5. Schöttke H, Giabbiconi CM. Post-stroke depression and post-stroke anxiety: prevalence and predictors. Int Psychogeriatr. 2015;27(11):1805-1812. https://doi.org/10.1017/S1041610215000988
  6. Reynolds GO, Hanna KK, Neargarder S, Cronin-Golomb A. The relation of anxiety and cognition in Parkinson’s disease. Neuropsychology. 2017;31(6):596-604.  https://doi.org/10.1037/neu0000353
  7. Wallis O, Bol Y, Köhler S, van Heugten C. Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints. Acta Neurol Scand. 2019; https://doi.org/10.1111/ane.13191
  8. Kanner AM. Psychiatric comorbidities in new onset epilepsy: should they be always investigated? Seizure. 2017;49:79-82.  https://doi.org/10.1016/j.seizure.2017.04.007
  9. Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric symptoms of multiple sclerosis: state of the art. Psychiatry Investig. 2019; https://doi.org/10.30773/pi.2019.0106
  10. Wen MC, Chan LL, Tan LC, Tan EK. Depression, anxiety, and apathy in Parkinson’s disease: insights from neuroimaging studies. Eur J Neurol. 2016;23(6):1001-1019. https://doi.org/10.1111/ene.13002
  11. Peres MFP, Mercante JPP, Tobo PR, Kamei H, Bigal ME. Anxiety and depression symptoms and migraine: a symptom-based approach research. J Headache Pain. 2017;18(1):37.  https://doi.org/10.1186/s10194-017-0742-1
  12. Johansson M, Stomrud E, Lindberg O, Westman E, Johansson PM, van Westen D, Mattsson N, Hansson O. Apathy and anxiety are early markers of Alzheimer’s disease. Neurobiol Aging. 2020;85:74-82.  https://doi.org/10.1016/j.neurobiolaging.2019.10.008
  13. Gay MC, Bungener C, Thomas S, Vrignaud P, Thomas PW, Baker R, Montel S, Heinzlef O, Papeix C, Assouad R, Montreuil M. Anxiety, emotional processing and depression in people with multiple sclerosis. BMC Neurol. 2017;17(1):43.  https://doi.org/10.1186/s12883-017-0803-8
  14. Gulpers B, Ramakers I, Hamel R, Köhler S, Oude Voshaar R, Verhey F. Anxiety as a predictor for cognitive decline and dementia: a systematic review and meta-analysis. Am J Geriatr Psychiatry. 2016;24(10):823-842  https://doi.org/10.1016/j.jagp.2016.05.015
  15. Santabárbara J, Lipnicki DM, Bueno-Notivol J, Olaya-Guzmán B, Villagrasa B, López-Antón R. Updating the evidence for an association between anxiety and risk of Alzheimer’s disease: a meta-analysis of prospective cohort studies. J Affect Disord. 2020;262:397-404.  https://doi.org/10.1016/j.jad.2019.11.065
  16. Schatzberg A, DeBattista C. Schatzberg’s Manual of Clinical Psychopharmacology (Ninth Edition). Washington: American Psychiatric Association Publishing, 2019;839. 
  17. Semple D, Smyth R. Oxford Handbook of Psychiatry (Fourth Edition). Oxford: Oxford University Press, 2019;1148.
  18. Generoso MB, Trevizol A, Kasper S, Cho HJ, Cordeiro Q, Shiozawa P. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis. Int Clin Psychopharmacol. 2017;32(1):49-55.  https://doi.org/10.1097/YIC.0000000000000147
  19. Ford AH, Almeida OP. Psychological treatment for depression and anxiety associated with dementia and mild cognitive impairment. Br J Psychiatry. 2015;207(4):286-287.  https://doi.org/10.1192/bjp.bp.115.166595
  20. Orgeta V, Qazi A, Spector A, Orrell M. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis. Br J Psychiatry. 2015;207(4):293-298.  https://doi.org/10.1192/bjp.bp.114.148130
  21. Maneeton N, Maneeton B, Woottiluk P, Likhitsathian S, Suttajit S, Boonyanaruthee V, Srisurapanont M. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2016;10:259-276.  https://doi.org/10.2147/DDDT.S89485
  22. Bailey MA, Saraswatula A, Dale G, Softley L. Paediatric sedation for imaging is safe and effective in a district general hospital. Br J Radiol. 2016;89(1061):20150483. https://doi.org/10.1259/bjr.20150483
  23. Hartz I, Skurtveit S, Steffenak AK, Karlstad Ø, Handal M. Psychotropic drug use among 0-17 year olds during 2004-2014: a nationwide prescription database study. BMC Psychiatry. 2016;16:12.  https://doi.org/10.1186/s12888-016-0716-x
  24. Otchet ob issledovanii biojekvivalentnosti lekarstvennogo preparata dlja medicinskogo primenenija. Nomer protokola: №TER-01-01-2015 ot 2015 g. Nazvanie issledovanija: Dvojnoe slepoe randomizirovannoe placebo-kontroliruemoe issledovanie po izucheniju bezopasnosti, perenosimosti i farmakokineticheskih parametrov preparatov Teralidzhen® retard, tabletki prolongirovannogo dejstvija, pokrytye plenochnoj obolochkoj, 20 mg, 40 mg i 60 mg (proizvodstva Otkrytogo Akcionernogo Obshhestva «Valenta Farmacevtika», Rossija) u zdorovyh dobrovol’cev. (In Russ.).
  25. National Institute for Health and Care Excellence (2011, updated 2019). Generalized anxiety disorder and panic disorder in adults: management. NICE guidance. Clinical guideline [CG113] https://www.nice.org.uk/guidance/cg113
  26. Goodarzi Z, Mele B, Guo S, Hanson H, Jette N, Patten S, Pringsheim T, Holroyd-Leduc J. Guidelines for dementia or Parkinson’s disease with depression or anxiety: a systematic review. BMC Neurol. 2016;16(1):244.  https://doi.org/10.1186/s12883-016-0754-5
  27. Patten SB. Psychopharmacology of multiple sclerosis. Handb Clin Neurol. 2019;165:309-315.  https://doi.org/10.1016/B978-0-444-64012-3.00018-6

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.